4D Molecular Therapeutics
- Biological Products, Except Diagnostic Substances
- Emeryville, California
Compensation history
Top executives at 4D Molecular Therapeutics received an average of $3M per person in annual compensation from 2019 to 2023.
Average pay of disclosed executives at 4D Molecular Therapeutics
By year
Executives
We found seven executives who work or worked at 4D Molecular Therapeutics.
David Kirn
4D Molecular Therapeutics
Chief Executive Officer
Fariborz Kamal
4D Molecular Therapeutics
Chief Operating Officer
Robert Kim
4D Molecular Therapeutics
Chief Medical Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics
Chief Medical Officer
News
4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
April 10, 2024
4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
April 12, 2023
4D Molecular Therapeutics CEO David Kirn's 2021 pay jumps 641% to $5.2M
April 13, 2022
4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
April 6, 2021
About 4D Molecular Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address5858 Horton Street #455, Emeryville, California 94608
- Phone5105052680
- Fiscal year endDecember 31
- Former names
- 4D Molecular Therapeutics Inc.Until May 11, 2022
- 4D Molecular Therapeutics IncUntil September 29, 2019
Source: SEC filings on April 10, 2024, April 12, 2023, April 13, 2022, and April 6, 2021.